Answers are grounded in this paper and cite their sources.
Systematic review estimates vitamin D deficiency prevalence in ataxia-telangiectasia, indicating significant clinical attention is needed.
Ataxia-telangiectasia (A-T) is a multisystem disorder in which nutritional and endocrine abnormalities are frequently reported. Vitamin D deficiency has been described in A-T cohorts, but its pooled prevalence within published A-T cohorts has not been quantified. We conducted a systematic review and single-arm meta-analysis to estimate the prevalence of vitamin D deficiency in A-T. We systematically identified observational studies reporting serum 25-hydroxyvitamin D 25(OH)D in individuals with A-T. The primary outcome was vitamin D deficiency prevalence using the study-defined threshold of 25(OH)D < 20 ng/mL. Secondary outcomes included severe deficiency (< 10 ng/mL), insufficiency, adequacy, and pooled mean 25(OH)D where available. Random-effects single-arm meta-analyses were performed. Study quality was assessed using the Newcastle-Ottawa Scale. Four studies were included. The pooled prevalence of vitamin D deficiency (< 20 ng/mL) was 50.8% (95% CI 39.4% to 62.2%), with I² = 0%. The pooled prevalence of severe deficiency (< 10 ng/mL) was 26.8% (95% CI 10.4% to 43.1%), with I² = 23%. The pooled prevalence of insufficiency was 21.9% (95% CI 7.6% to 36.1%), with I² = 0%, and adequacy was 38.1% (95% CI 19.5% to 56.8%), with I² = 55.1%. The pooled mean 25(OH)D was 19.65 ng/mL (95% CI 16.26 to 23.04), with I² = 30.7%. Vitamin D deficiency is common in published A-T cohorts, with approximately half meeting a < 20 ng/mL threshold. These findings support routine clinical attention to 25(OH)D in A-T, while highlighting the need for standardized, outcome-focused prospective studies and interventional trials.
No takes yet. Share an insight, caveat, or question.
Iqbal et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: